Skip to Main Content

Paper Details

A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
Oncotarget
7
2017
Author NameAffiliation
Itzhak AvitalP8-Medicine Ltd
Itzhak AvitalP8-Medicine Ltd
  • 1 - 2

Datasets

Release 1.2